Find Funding Opportunities

COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements
NINDS Interest in Pain Research | View information, FAQs, resources, and available funding notices and opportunities.

All NINDS-related funding opportunity announcements (FOAs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed.Search the Closed Announcements tab to find expired opportunities. Search the Notices tab to find all Notices.

Learn more about award types and program directors and managers.

NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!

Expiration Date: Friday, June 21, 2024FOA Number: NOT-NS-23-002Release Date: Wednesday, August 3, 2022Announcement Type: Notice of Special Interest
This Notice of Special Interest (NOSI) encourages the translation of the novel neurotechnologies, funded through the Helping to End Addiction Long-Term (HEAL) Initiative and overseen by the NIH Blueprint MedTech program. Academic and Small Business Concerns (SBCs) are encouraged to submit grant applications that propose non-clinical validation for subsequent clinical feasibility studies. Applications supporting the development and translation of groundbreaking neurotechnologies that fit within the mission of the HEAL Initiative are encouraged.
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-NS-23-020Release Date: Tuesday, August 2, 2022Announcement Type: NOT
Correcting total vs direct cost in the text.
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-NS-23-009Release Date: Friday, July 29, 2022Announcement Type: NOT
NOITP
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-NS-22-120Release Date: Thursday, July 28, 2022Announcement Type: NOT
This FOA should be a reissue of PAR-21-236.
Expiration Date: Tuesday, July 1, 2025FOA Number: NOT-AT-22-027Release Date: Wednesday, July 27, 2022Announcement Type: Notice of Special Interest
This Notice of Special Interest (NOSI) is being issued by the National Center for Complementary and Integrative Health (NCCIH) with participation from multiple NIH Institutes, Centers, and Offices (ICOs). This NOSI aims to promote mechanistic research of therapeutic benefits of minor cannabinoids and terpenes in the cannabis plant. Minor cannabinoids are defined as any and all cannabinoids from the cannabis plant other than ?9-tetrahydrocannabinol (?9-THC). Cannabinoids of particular interest include the following: ?8-THC, Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC), cannabichromevarin (CBDV), tetrahydrocannabivarin (THCV), Tetrahydrocannabivarin acid (THCVA), tetrahydrocannabinolic acid (THCA), carmagerol, cannabicitran, sesquicannabigerol. Terpenes of particular interest include the following: Myrcene, -caryophyllene, Limonene, ? -terpineol, Linalool, ?-phellandrene, ?-pinene, -pinene, ?-terpinene, and ?-humulene. This NOSI intends to support highly innovative basic and/or mechanistic studies in appropriate model organisms and/or human subjects aiming to investigate the impact of minor cannabinoids and terpenes on mechanisms underlying their therapeutic effects. Preclinical studies of combinations of minor cannabinoids with terpenes or other natural products that may enhance their therapeutic benefits and/or abate unwanted effects are encouraged.
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-NS-23-005Release Date: Wednesday, July 27, 2022Announcement Type: NOT
This notice informs the public that, effective in Fiscal Year 2022 (FY2022), NINDS will raise the maximum salary support provided to clinician-scientists on Career Development (K) awards for the related funding opportunity announcements listed above. The new cap on salary provided for clinician-scientists supported by individual, mentored K awards (K01, K08, K22, K23, K99) will be $125,000; supported by individual, independent K awards (K02) will be $150,000; supported by institutional K awards (K12) will be $115,000.
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-NS-22-108Release Date: Tuesday, July 26, 2022Announcement Type: NOT
The purpose of this notice is to inform potential applicants of a change to the maximum salary for clinician scientists for PAR-21-327 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 - Clinical Trial Required)" and PAR-21-328 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 - Clinical Trial Not Allowed)". Effective in FY 2022, NINDS will raise the maximum salary support provided to clinician-scientists on Career Development (K) awards. The new cap on salary provided for clinician-scientists supported by the K01 will be $125,000.00.
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-NS-22-109Release Date: Tuesday, July 26, 2022Announcement Type: NOT
The purpose of this notice is to inform potential applicants of a change to the maximum salary for clinician scientists for PAR-22-022 "NINDS Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)". Effective in FY 2022, NINDS will raise the maximum salary support provided to clinician-scientists on Career Development (K) awards. The new cap on salary provided for clinician-scientists supported by the K99 will be $125,000.00.
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-NS-22-107Release Date: Tuesday, July 26, 2022Announcement Type: NOT
The purpose of this notice is to inform potential applicants of a change to the maximum salary for clinician scientists for PAR-21-153 "NINDS faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required)" and PAR-21-234 "NINDS faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)". Effective in FY 2022, NINDS will raise the maximum salary support provided to clinician-scientists on Career Development (K) awards. The new cap on salary provided for clinician-scientists supported by the K01 will be $125,000.00.
Expiration Date: Wednesday, January 1, 2025FOA Number: NOT-NS-23-019Release Date: Monday, July 25, 2022Announcement Type: NOT
This Notice is to announce the availability of an informational webinar video with overview information on program goals, application instructions, and project responsiveness for RFA-NS-22-036, which are the initiating FOA for NINDS Interdisciplinary Team Science Grant (RM1 Clinical Trial Optional). The pre-recorded video is optional and is not required for submission of an application.